References
- 1. J. Y. Park and S. H. Jang, Epidemiology of lung cancer in Korea: Recent trends, Tuberc. Respir. Dis. (Seoul).79 (2016) 58–69; DOI: 10.4046/trd.2016.79.2.58.
- 2. S. C. Gupta, S. Patchva, W. Koh and B. B. Aggarwal, Discovery of curcumin, a component of golden spice, and its miraculous biological activities, Clin. Exp. Pharmacol. Physiol.39 (2012) 283–299; DOI: 10.1111/j.1440-1681.2011.05648.x.
- 3. H. Mahammedi, E. Planchat, M. Pouget, X. Durando, H. Curé, L. Guy, I. Van-Praagh, L. Savareux, M. Atger, M. Bayet-Robert, E. Gadea, C. Abrial, E. Thivat, P. Chollet and J. C. Eymard, The new combination docetaxel, prednisone and curcumin in patients with castration-resistant prostate cancer: A Pilot Phase II Study, Oncology90 (2016) 69–78; DOI: 10.1159/000441148.
- 4. S. C. Gupta, G. Kismali and B. B. Aggarwal, Curcumin, a component of turmeric: from farm to pharmacy, Biofactors39 (2013) 2–13; DOI: 10.1002/biof.1079.
- 5. D. Perrone, F. Ardito, G. Giannatempo, M. Dioguardi, G. Troiano, L. Lo Russo, L. A. De, L. Laino and L. Lo Muzio, Biological and therapeutic activities, and anticancer properties of curcumin, Exp. Theor. Med.10 (2015) 1615–1623.
- 6. M. Kanai, Y. Otsuka, K. Otsuka, M. Sato, T. Nishimura, Y. Mori, M. Kawaguchi, E. Hatano, Y. Kodama, S. Matsumoto, Y. Murakami, A. Imaizumi, T. Chiba, J. Nishihira and H. Shibata, A phase I study investigating the safety and pharmacokinetics of highly bioavailable curcumin (Theracurmin) in cancer patients, Cancer Chemother. Pharmacol.71 (2013) 1521–1530; DOI: 10.1007/s00280-013-2151-8.
- 7. H. A. Hazzah, R. M. Farid, M. M. Nasra, M. A. El-Massik and O. Y. Abdallah, Lyophilized sponges loaded with curcumin solid lipid nanoparticles for buccal delivery: Development and characterization, Int. J. Pharm.492 (2015) 248–257; DOI: 10.1016/j.ijpharm.2015.06.022.
- 8. F. Foglietta, L. Serpe, R. Canaparo, N. Vivenza, G. Riccio, E. Imbalzano, P. Gasco and G. P. Zara, Modulation of butyrate anticancer activity by solid lipid nanoparticle delivery: an in vitro investigation on human breast cancer and leukemia cell lines, J. Pharm. Pharm. Sci.17 (2014) 231–247.
- 9. N. Naseri, H. Valizadeh and P. Zakeri-Milani, Solid lipid nanoparticles and nanostructured lipid carriers: structure, preparation and application, Adv. Pharm. Bull.5 (2015) 305–313; DOI: 10.15171/apb.2015.043.
- 10. R. H. Müller, R. Shegokar and C. M. Keck, 20 years of lipid nanoparticles (SLN and NLC): Present state of development and industrial applications, Curr. Drug. Discov. Technol.8 (2011) 207–227.
- 11. S. Selvamuthukumar and R. Velmurugan, Nanostructured lipid carriers: a potential drug carrier for cancer chemotherapy, Lipids Health Dis.11 (2012) 159; DOI: 10.1186/1476-511X-11-159.
- 12. J. Chen, W. T. Dai, Z. M. He, L. Gao, X. Huang, J. M. Gong, H.Y. Xing and W. D. Chen, Fabrication and Evaluation of Curcumin-loaded Nanoparticles Based on Solid Lipid as a New Type of Colloidal Drug Delivery System, Indian J. Pharm. Sci.75 (2013) 178–184.
- 13. W. H. Lee, C. Y. Loo, P. M. Young, D. Traini, R. S. Mason and R. Rohanizadeh, Recent advances in curcumin nanoformulation for cancer therapy, Expert Opin. Drug Deliv.11 (2014) 1183–1201; DOI: 10.1517/17425247.2014.916686.
- 14. Q. Y. Chen, Y. Zheng, D. M. Jiao, F.Y. Chen, H. Z. Hu, Y. Q. Wu, J. Song, J. Yan, L. J. Wu and G. Y. Lv, Curcumin inhibits lung cancer cell migration and invasion through Rac1-dependent signaling pathway, J. Nutr. Biochem.25 (2014) 177–185; DOI: 10.1016/j.jnutbio.2013.10.004.
- 15. M. Cao, L. Ren and G. Chen, Formulation optimization and ex vivo and in vivo evaluation of celecoxib microemulsion-based gel for transdermal delivery, AAPS PharmSciTech. (2016) Dec 2. [Epub ahead of print].
- 16. C. Hasovits and S. Clarke, Pharmacokinetics and pharmacodynamics of intraperitoneal cancer chemotherapeutics, Clin. Pharmacokinet.51 (2012) 203–224; DOI: 10.2165/11598890-000000000-00000.
- 17. S. K. Williamson, G. A. Johnson, H. A. Maulhardt, K. M. Moore, D. S. McMeekin, T. K. Schulz, G. A. Reed, K. F. Roby, C. B. Mackay, H. J. Smith, S. J. Weir, J. A. Wick, M. Markman, G. S. diZerega, M. J. Baltezor, J. Espinosa and C. J. Decedue, A phase I study of intraperitoneal nanoparticulate paclitaxel (Nanotax®) in patients with peritoneal malignancies, Cancer Chemother. Pharmacol.75 (2015) 1075–1087; DOI: 10.1007/s00280-015-2737-4.
- 18. P. Maincent, P. Thouvenot, C. Amicabile, M. Hoffman, J. Kreuter, P. Couvreur and J. P. Devissaguet, Lymphatic targeting of polymeric nanoparticles after intraperitoneal administration in rats, Pharm. Res.9 (1992) 1534–1539.
- 19. S. Kommareddy, S. B. Tiwari and M. M. Amiji, Long-circulatin polymeric nanovectors for tumorselective gene delivery, Technol. Cancer Res. Treat.4 (2005) 615–625.
- 20. R. Tiwari and K. Pathak, Nanostructured lipid carrier versus solid lipid nanoparticles of simvastatin: comparative analysis of characteristics, pharmacokinetics and tissue uptake, Int. J. Pharm.415 (2011) 232–243; DOI: 10.1016/j.ijpharm.2011.05.044.
- 21. M. Fang, Y. Jin, W. Bao, H. Gao, M. Xu, D. Wang, X. Wang, P. Yao and L. Liu, In vitro characterization and in vivo evaluation of nanostructured lipid curcumin carriers for intragastric administration, Int. J. Nanomedicine7 (2012) 5395–5404; DOI: 10.2147/IJN.S36257.
- 22. D. Zheng, W. Dai, D. Zhang, C. Duan, L. Jia, Y. Liu and Q. Zhang, In vivo studies on the oridonin-loaded nanostructured lipid carriers, Drug Deliv.19 (2012) 286–291; DOI: 10.3109/10717544.2012.704096.
- 23. C. Mohanty and S. K. Sahoo, The in vitro stability and in vivo pharmacokinetics of curcumin prepared as an aqueous nanoparticulate formulation, Biomaterials31 (2012) 6597–6611. DOI: 10.1016/j.biomaterials.2010.04.062.
- 24. H. Rosen and T. Abribat, The rise and rise of drug delivery, Nat. Rev. Drug Discov.4 (2005) 381–385.
- 25. D. Breznan, D. D. Das, J. S. O’Brien, C. MacKinnon-Roy, S. Nimesh, N. Q. Vuong, S. Bernatchez, N. DeSilva, Hill M, P. Kumarathasan, R. Vincent, Differential cytotoxic and inflammatory potency of amorphous silicon dioxide nanoparticles of similar size in multiple cell lines, Nanotoxicology. 1 (2017) 1–45. DOI: 10.1080/17435390.2017.1287313.
- 26. J. H. Duan, Y. D. Zhang, S. W. Han, Y. X. Chen, B. Li, M. M. Liao, W. Chen, X. M. Deng, J. F. Zhao and B. Y. Huang, Synthesis and in vitro/in vivo anti-cancer evaluation of curcumin-loaded chitosan/poly(butyl cyanoacrylate) nanoparticles, Int. J. Pharm.400 (2010) 211–220.
- 27. S. Lev-Ari, L. Strier, D. Kazanov, O. Elkayam, D. Lichtenberg, D. Caspi and N. Arber, Curcumin synergistically potentiates the growth-inhibitory and pro-apoptotic effects of celecoxib in osteoarthritis synovial adherent cells, Rheumatology (Oxford)45 (2006) 171–177.
- 28. S. Lev-Ari, A. Vexler, A. Starr, M. Ashkenazy-Voghera, J. Greif, D. Aderka and R. Ben-Yosef, Curcumin augments gemcitabine cytotoxic effect on pancreatic adenocarcinoma cell lines, Cancer Invest.25 (2007) 411–418.